12/18/2024
3:45 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:17 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
3:34 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
6:14 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:25 PM | Kiniksa Pharmaceuticals (Subject)
Ragosa Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
4:13 PM | Kiniksa Pharmaceuticals (Subject)
Megna Michael R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
4:50 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/14/2024
3:32 PM | HHLR ADVISORS, LTD. (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
3:30 PM | Kiniksa Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
11/06/2024
3:11 PM | Kiniksa Pharmaceuticals (Subject)
Patel Sanj K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
3:14 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
6:31 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13G | |
10/17/2024
3:35 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:57 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
4:29 PM | BAKER BROS. ADVISORS LP (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13D/A | |
10/08/2024
4:08 PM | Boyd Meta Cantey (Reporting)
Kiniksa Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
3:40 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:14 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kiniksa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:39 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
4:02 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
7:57 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:51 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:52 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:53 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:55 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:42 PM | Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
4:16 PM | Kiniksa Pharmaceuticals (Subject)
Paolini John F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
4:17 PM | Kiniksa Pharmaceuticals (Subject)
Moat Ross (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
3:36 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
4:17 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
3:31 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
3:32 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
3:33 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
3:10 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/23/2024
6:54 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/04/2024
11:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form EFFECT | |
07/04/2024
11:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form EFFECT | |
06/30/2024
11:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form EFFECT | |
06/28/2024
4:29 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/28/2024
4:30 PM | Kiniksa Pharmaceuticals (Filer)
| Form 15-15D | |
Vladimir Lenin was right… (Ad) The Magnificent 7 could be in for a world of pain…
And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock.
The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on.
It’s called The Final Frontier. Including the name of the #1 company to buy. |
06/28/2024
4:22 PM | Kiniksa Pharmaceuticals (Filer)
| Form POS AM | |
06/28/2024
4:22 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024
4:23 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024
4:23 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024
4:24 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024
4:24 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024
4:25 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/27/2024
8:34 PM | Kiniksa Pharmaceuticals (Filer)
| Form POS AM | |
06/25/2024
3:30 PM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
3:27 PM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:35 PM | Kiniksa Pharmaceuticals (Issuer)
Quart Barry D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:36 PM | Kiniksa Pharmaceuticals (Issuer)
Popovits Kimberly J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:37 PM | Kiniksa Pharmaceuticals (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:39 PM | Kiniksa Pharmaceuticals (Issuer)
Malley Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:40 PM | Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:41 PM | Cole G Bradley (Reporting)
Kiniksa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:27 PM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
4:19 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
05/07/2024
3:46 PM | Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:35 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:36 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2024
3:41 PM | Kiniksa Pharmaceuticals (Filer)
| Form ARS | |
04/23/2024
3:43 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
3:46 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
6:34 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
4:00 PM | Kiniksa Pharmaceuticals (Filer)
| Form PRE 14A | |
04/08/2024
4:20 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:21 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:22 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:17 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:18 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:19 PM | Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
11:21 AM | BlackRock Inc. (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/03/2024
4:22 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:23 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:25 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
6:32 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
4:00 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
03/29/2024
6:30 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
6:30 AM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
03/11/2024
6:05 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:37 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:24 PM | Kiniksa Pharmaceuticals (Subject)
Patel Sanj K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
5:26 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:29 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
4:31 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2024
6:35 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:46 PM | Fairmount Funds Management LLC (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
5:06 AM | Kiniksa Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G | |
01/04/2024
6:37 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Vladimir Lenin was right… (Ad) The Magnificent 7 could be in for a world of pain…
And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock.
The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on.
It’s called The Final Frontier. Including the name of the #1 company to buy. |
12/21/2023
3:26 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
